Literature DB >> 19453340

The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings.

A Młynek1, M Magerl, M Hanna, S Lhachimi, I Baiardini, G W Canonica, Z Brzoza, A Kasperska-Zajac, B Rogala, A Zalewska-Janowska, T Zuberbier, M Maurer.   

Abstract

BACKGROUND: Chronic urticaria (CU) is a common skin disorder that causes a substantial burden on patients' quality-of-life (QoL). The aim of this work was to generate and validate a German version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q(2)oL) and to provide reference assessments of QoL.
METHODS: The Italian CU-Q(2)oL was translated into German and administered to 157 CU patients. They also completed two well-established general dermatology QoL questionnaires, the Dermatology Life Quality Index (DLQI) and Skindex-29. Factor analysis was used to identify scales of the German CU-Q(2)oL. Correlation to the DLQI and Skindex-29 was used for validation. Multiple linear regression was used to determine which patient characteristics were associated with which dimensions of QoL.
RESULTS: The factor analysis identified six scales of the German CU-Q(2)oL: functioning, sleep, itching/embarrassment, mental status, swelling/eating, and limits looks, which accounted for 70% of the data variance. Five of these six scales showed good internal consistency, and another five demonstrated convergent validity. On a percentile scale, they had these median CU-Q(2)oL scores: 29 functioning, 44 sleep, 50 itching/embarrassment, 50 mental status, 31 swelling/eating, 31 limits looks. Disease severity significantly predicted scores on all scales. Age predicted functioning, sleep, itching/embarrassment, and swelling/eating. Sex predicted itching/embarrassment and limits looks.
CONCLUSION: This study yielded a robust validation of the German version of the CU-Q(2)oL. It confirmed previous studies that CU has a clinically meaningful burden on QoL, especially for sleep and mental health, and that women are more severely affected by pruritus. The German CU-Q(2)oL should be widely adopted in clinical research on the treatment of CU.

Entities:  

Mesh:

Year:  2009        PMID: 19453340     DOI: 10.1111/j.1398-9995.2008.01920.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  31 in total

1.  [Useful tools for documenting urticaria].

Authors:  P Staubach; A Groffik
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

Review 2.  [Diagnosis and therapy of chronic urticaria-what is expected from the revision and update of the international guidelines? A report of the public consensus conference "URTICARIA 2012"].

Authors:  M Maurer; M Magerl; M Metz; T Zuberbier
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

3.  Cold-induced urticaria: challenges in diagnosis and management.

Authors:  Elana Fay Hochstadter; Moshe Ben-Shoshan
Journal:  BMJ Case Rep       Date:  2013-07-08

Review 4.  Urticaria Guidelines: Consensus and Controversies in the European and American Guidelines.

Authors:  Lauren M Fine; Jonathan A Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

5.  A Summary of the New International EAACI/GA 2 LEN/EDF/WAO Guidelines in Urticaria.

Authors:  Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2019-04-30       Impact factor: 4.084

6.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 7.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

8.  A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria.

Authors:  Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-01-13       Impact factor: 4.084

9.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

10.  Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.

Authors:  Martin Metz; Karsten Weller; Claudia Neumeister; Iñaki Izquierdo; Rolf-Hasso Bödeker; Ulrich Schwantes; Marcus Maurer
Journal:  Dermatol Ther (Heidelb)       Date:  2015-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.